PATH and our partners have been advancing innovative vaccine technologies for more than 30 years. This report outlines our approach and capabilities. It also describes a number of individual vaccine technologies at various stages of development and market introduction to put this work in context. 

Corporate author(s): PATH

Publication date: September 2010

Available materials


Some digital files may be saved at low resolutions to conserve file size. Versions with higher quality may be available; see the contact information below to enquire.

Related regions: Global

See also:

For more information…

Contact: PATH Publications
Mailing address: PATH, PO Box 900922, Seattle, WA 98109 USA